Growth stocks are crumbling fast these days. Inflation and geopolitical issues have contributed to top stocks like Apple and Amazon falling more than 20% since the start of the year. While those businesses could face headwinds this year as inflation and supply-chain issues weigh on their operations, there's one growth-oriented company that has fallen this year but still expects strong performance in its current fiscal year: Doximity (NYSE: DOCS).
Despite beating analysts' estimates during its latest quarter, Doximity (NYSE: DOCS) stock took another nosedive after results were released this week. Investors who like companies using technology to serve customers but who are rattled by the tech sell-off should spend some time getting to know Doximity. Here's why this emerging healthcare leader is worth a look right now.